200 related articles for article (PubMed ID: 18191073)
1. The metabolic syndrome in type 1 diabetes: does it exist and does it matter?
McGill M; Molyneaux L; Twigg SM; Yue DK
J Diabetes Complications; 2008; 22(1):18-23. PubMed ID: 18191073
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
4. The metabolic syndrome in type 2 diabetes: When does it matter?
Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
[TBL] [Abstract][Full Text] [Related]
5. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15).
Mohan V; Gokulakrishnan K; Deepa R; Shanthirani CS; Datta M
Diabet Med; 2005 Sep; 22(9):1206-11. PubMed ID: 16108850
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome and its cardiovascular manifestations.
Sánchez-Torres RJ; Delgado-Osorio H
Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus.
Ahamed A; Shantha GP; Agarwal G; Senthil N; Paunikar N; Sudhakar MK
J Indian Med Assoc; 2008 Sep; 106(9):583-4, 586, 588. PubMed ID: 19552085
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
9. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
Haddad FH; Mahafza SM
Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
[TBL] [Abstract][Full Text] [Related]
10. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
11. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
; Bonadonna R; Cucinotta D; Fedele D; Riccardi G; Tiengo A
Diabetes Care; 2006 Dec; 29(12):2701-7. PubMed ID: 17130208
[TBL] [Abstract][Full Text] [Related]
12. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
Gazzaruso C; Solerte SB; De Amici E; Mancini M; Pujia A; Fratino P; Giustina A; Garzaniti A
Am J Cardiol; 2006 Jan; 97(2):236-9. PubMed ID: 16442369
[TBL] [Abstract][Full Text] [Related]
13. Metabolic risk factors associated with erosive esophagitis.
Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
15. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
Moin S; Gondal GM; Bano U
J Coll Physicians Surg Pak; 2008 Aug; 18(8):472-6. PubMed ID: 18798582
[TBL] [Abstract][Full Text] [Related]
16. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
[TBL] [Abstract][Full Text] [Related]
17. Macrovascular complications of metabolic syndrome: an early intervention is imperative.
Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ
Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679
[TBL] [Abstract][Full Text] [Related]
18. [Prehypertension in type 1 diabetic children and adolescents].
Szadkowska A; Pietrzak I; Mianowska B; Czerniawska E; Bodalska-Lipińska J; Chrul S; Markuszewski L; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):286-91. PubMed ID: 17239307
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.
Chen YJ; Wu CY; Shen JL; Chu SY; Chen CK; Chang YT; Chen CM
Arch Dermatol; 2008 Dec; 144(12):1571-5. PubMed ID: 19075139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
